These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17631182)

  • 1. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG; Bug G; Krauter J
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
    Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
    Johnston EM; Crawford J
    Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
    Lehrnbecher T; Creutzig U
    Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.
    Dombret H; Toubert ME; Schlageter MH; Chomienne C; Degos L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):445-8. PubMed ID: 1726333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects.
    Büchner T; Hiddemann W; Wörmann B; Zühlsdorf M; Rottmann R; Innig G; Maschmeier G; Ludwig WD; Sauerland MC; Heinecke A
    Semin Oncol; 1997 Feb; 24(1):124-31. PubMed ID: 9045298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
    Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic growth factors and cancer-related neutropenia: limited effects.
    Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines in the treatment of acute leukemias: a review.
    Ravandi F
    Leukemia; 2006 Apr; 20(4):563-71. PubMed ID: 16498390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of colony stimulating factors for established neutropenic fever.
    Walton SM
    W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte macrophage--colony stimulating factor (GM-CSF) as adjunct in induction therapy of acute myeloid leukemia.
    Gangadharan VP; Prakash NP; Jayasree K; Nayak N
    Indian J Cancer; 1999 Mar; 36(1):32-7. PubMed ID: 10810552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine therapy for hematological malignancies.
    Ezaki K; Tsuzuki M
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():182-94. PubMed ID: 9210900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
    Cucuianu A; Petrov L; Ghiurt A; Vasilache A
    Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    Tóthová E
    Vnitr Lek; 1998 Jun; 44(6):373-7. PubMed ID: 9820064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.